Welcome to AmDen!
Amden facilitates collaboration between US pharmaceutical companies and EU producers of mainly 505(b)2 pharmaceuticals (modified generics), New Chemical Entities (NCE), and clinical trials. For US companies selling pharmaceuticals, Amden is able to locate new pharmaceuticals produced and marketed outside the USA to add to your portfolio. Affiliated with over 4600 pharma companies globally, Amden will present your company with several potential options for US licensing. We will concentrate on finding pharmaceuticals in your area of interest.
If you are developing pharmaceuticals and are interested in finding companies in the EU that will in-license your products or engage in co-development, AmDen can provide professional assistance. We identify potential partners for your company with respect to collaborating on projects in phase II or III, or projects ready for approval and launch.
Tap into AmDen’s vast network of 4600+ global companies and 40+ years of expertise to expand your portfolio. Click here to unlock your pathway to profitable collaborations and market success with AmDen!
Discover the background of AmDen’s powerhouse team, ranging from extensive pharmaceutical leadership to biotech innovation, medical and business ventures, long-term care expertise, and strategic development.
Need assistance or have specific queries? Reach out to AmDen for personalized support and detailed explanations to help your business thrive. We’re at your service, so don’t hesitate to contact us.
AmDen Pharmaceuticals, LLC, is a privately-owned US and EU based Pharmaceutical company. Our vision is to be recognized as the most innovative, collaborative, and responsive company in the 505(b)2 (modified generics) pharmaceutical industry.